Russian Federation
Russian Federation
Russian Federation
Russian Federation
Consequences of the new coronavirus infection remain a serious healthcare problem all over the world and this study is dedicated to elaboration of treatment and diagnostic procedures for the patients with post-COVID liver damage.
post-COVID-19 liver damage, post-COVID-19 hyperammoniemia, liver dysfunction, ursodeoxycholic acid.
1. Naee1n M., Bano N., Manzoor S., Ahn1ad A., Mtt11a,var N., Razak S.I.A., Lee T.U., Devap1j S., Hazafa A. Pathogenetic Mechanisms of Liver-Associated lnjuries, Manage1nent, and Current Cl1alle11ges in COVID-19 Patie111s // Bio1nolecules. -2023 Jan 3; 13( 1):99. Doi: 10.3390/'iom 13010099
2. Luo M., Ballester M.R., Soffienlini U., Jala11 R., Melna G. SARS-CoV-2 infectio11 and liver involve111enl // Hepatol lnt. - 2022 Aug; 16(4):755-774. Doi:https://doi.org/10.1007/s 12072-022-10364-1
3. Joan V. Soriano (Senior Const1ltan1), Maua Allan, Carine Alsokl1n, Nisreen A AI,van, Lisa Askie, Hannah E Davis, Janet V Diaz, Tarun Dua, Wouter de Groote, Robcrt Jakob, Marta Lado, Jol111 Marsl1all, Sri11 Murthy, Jacobt1s Preller, Pryapka Rela11, Nicolipe Schiess, A1·chana Seahwag; Wogld Health Organizatio11. A clinical case defi nition of post COVID-19 condition 'u a Delphi consensus, 6 October 2021. (\.VH0/2019-11CoV/Pos1_ SOVSh-19 _condi1io11/ Clinical_case_defi nition/2021.1 accessed 31 August 2022).
4. Ahsan K., An,var M.A., Muna,var N. Gt1t 1nicr0'io1ne tl1erapeutic n1odt1lation to alleviate drug-induced l1epa1ic dainage in COVID-19 patients // World J Gastroenterol. -2023 Mai· 21; 29(11 ): 1708-1720. Doi: I0.3748/,vjg.v29.i 11.1708
5. Ramalho S., Martips-Mendes O., Macedo J.M., Barros S., Lt1is S., S,1 S., Gestoso A., Pereira A.S., Baylina R., Femandes R. Unveili11g the Path \o Resilie11ce: Prioritizing Meptal Health, Sleep, and Nutrition in the Post-COVID Era // Heal1l1cai·e (Basel). - 2023 Sep 4; 11 ( 17): 2463. Doi:https://doi.org/10.3390/l1eallhcai·e 11 172463
6. Subrainanian S., lles T., lkrainuddin S., Steer C.J. Merit of an Ursodeoxycl10l ic Acid Clinical Trial in COVID-19 Patie111s // Vaccipes (Basel). - 2020 Jt111 19; 8(2): 320. Doi:https://doi.org/10.3390/vaccines8020320
7. Tln1u R.H., Vao T.D.D., Moo11 E.U. Ursodeoxycliolic acid a111eliorates cell n1igration retarded 'u the SARS-Co V-2 spike protei11 in BEAS-28 l1uman broncl1ial epitl1elial cells // Biomed Phapnacother. -2022 Ju11; 150: 1 13021. Doi: 10.1O16/j.'iopha.2022.1 13021. Epub 2022 Apr 25.
8. Li U., Zl1u N., Cui H., Lin U., Li H. Protecti,,e effect ofursodeoxycholic acid op COVID-19 in patiepts \vith ch1·011ic liver disease // Fro111 Cell lnfect Micro'iol. - 2023 Mau 3; 13: 1178590. Doi:https://doi.org/10.3389/fcimb.2023.1178590
9. Tihonov I.N., Ivashkin V.T., Zharkova M.S. i dr. Rezul'taty neintervencionnoy iablodatel'noy rrorrammy «Vniyanie novogo koronavirusa na sosoyanie pacientov s zabolevaniyami 11s•1eni i zheludochno-kishechnogo trakta i vliyan11e preparatov ursodezoksiholevoy kisloty i rebamipida na techenie infekcii COVID-19 (KONTUR)»// Medic11nskiy sovet. - 2021. -№ 21-1. -S. 106-119.- Doi:https://doi.org/10.21518/2079-701H-2021-21-1-106-119
10. Ostroumova 0.D., Pereverzev A.P., Pavleeva E.E., Romanovskiy R.R. Antibiotikassociirovannoe lekarstvenno-inducirovannoe porazhenie pecheni s holestazom: aktualizaciya problemy v epohu COVID-19 // Medicinskiy a.11favit. - 2021. - № 1. - S. 31-43. - Doi: 1O.33667/2078-5631-2021-1-31-43.
11. Vyalov S.S., Gil1ok A.V. Porazhenie pecheni i zhelchevyvodyaschih purey, inducirovannoe koronavirusnoy infekciey SARS-CoV-2 // Terapiya. - 2022. - T. 8, № 6(58). - S. 140-150. Doi: 10. l 8565/therapy.2022.6.140-150
12. Il'chenko L.10., Nikitin I.G., sl)edorov I.G., Totolyan G.G. Ursodezoksiholsvaya kislota i SOVID-19-associirovannoe porazhenie pe•1en11 // Lechebnoe delo. - 2021. - № 3. - S. 40-50. Doi:https://doi.org/10.24412/2071-5315-2021 -12358
13. Grinevi•1 V.B., Lazebnik L.B., Kravchuk !O.A. i dr. Porazhet1iya organov pischevareniya pri postkovidnom sindrome. Klinicheskie rekomendacii // Eksperimental'naya i kl11nicheskaya gastroenterolop1ya. -2022. -№ 12(208). -S. 4-68. -Doi: I0.31146/1682-8658-ecg-208-12-4-68.
14. Medvedev 10.V., Bakulin I.G., Nemcova E.G. i dr. Innovacii v primenenii 13S-metacet11novoro dyhatel'nogo testa dlya ocenki stepeni fibroza pecheni // Doktor.Ru. - 2019. -№ 8( 163). - S. 6-12.
